Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.

Antimicrobial agents and chemotherapy - 1 Jun 1997

Tanaka M, Hohmura M, Nishi T, Sato K, Hayakawa I

Abstract excerpt

The in vitro antibacterial activity of DU-6681a, a parent compound of DZ-2640, against gram-positive and -negative bacteria was compared with those of penems and cephalosporins currently available. MICs at which 90% of the isolates are inhibited (MIC90s) of the compound for clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to beta-Lactamases
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enzyme Stability

Share to Gram-Negative Bacteria

Share to Kinetics

Share to Microbial Sensitivity Tests

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 9174181
DOI: 10.1128/AAC.41.6.1260
PMCID: PMC163897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.PMID 9174181Read ↗

In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Semantic proximity Read ↗

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsSemantic proximity Read ↗

In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanisms.Semantic proximity Read ↗

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.Semantic proximity Read ↗

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.Semantic proximity Read ↗

Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.Semantic proximity Read ↗

Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.Semantic proximity Read ↗

In Vitro and In Vivo Antibacterial Activities of DC-159a, a New FluoroquinoloneSemantic proximity Read ↗

In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.Semantic proximity Read ↗

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.Semantic proximity Read ↗

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.Semantic proximity Read ↗

Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.